Market Dynamics The global Impetigo Treatment market is anticipated to demonstrate a strong revenue compound annual growth rate (CAGR) during the forecast period spanning from 2019 to 2030. Market revenue growth is primarily fueled by the increase in infectious diseases, a rising percentage of individuals with compromised immunity, the escalating use of antibiotics, and a growing infant population. Impetigo, also known as school sores, is a type of skin infection that predominantly affects infants and young children. It is highly contagious and typically manifests as red sores around the nose and mouth. Impetigo is caused by one or both of the bacteria, Streptococcus and Staphylococcus aureus.
According to the World Health Organization (WHO), approximately 162 million individuals worldwide suffer from impetigo.
Factors Supporting Market Growth Drivers The impetigo treatment market is driven by several factors, including the surge in infectious disease outbreaks and a patient population with weakened immune systems. According to the U.S. Centers for Disease Control and Prevention, 3% of the U.S. population suffers from weakened immune systems.
Get a sample copy of the Impetigo Market report: https://www.reportsanddata.com/download-free-sample/5355
Global increases in antibiotic usage, the rise in hospital-acquired infections, an expanding infant population, and the adoption of unhygienic lifestyles in developing nations are key drivers of market growth. Additionally, the growing demand for broad-spectrum antibiotics, ongoing research and development efforts to enhance the quality of impetigo treatment drugs, and increased healthcare spending contribute to market growth. Notably, global antibiotic consumption increased by 65% between 2000 and 2015.
Impetigo Market: Drive factors
Factors Driving the Impetigo Treatment Market:
1. Increase in Infectious Diseases: The impetigo market is being driven by a global increase in infectious diseases. Impetigo itself is a contagious skin infection, and the rise in various infectious diseases contributes to the demand for impetigo treatment.
2. Weakened Immunity Disorders: The market is witnessing growth due to an increasing percentage of individuals with weakened immunity disorders. These individuals are more susceptible to impetigo and seek treatment.
3. Rising Antibiotic Usage: The widespread use of antibiotics is a significant driver of the impetigo treatment market. Impetigo often requires antibiotic treatment, and the escalating use of antibiotics fuels market growth.
4. Increasing Infant Population: With a growing population of infants and young children, the likelihood of impetigo cases rises. This demographic factor plays a vital role in the expansion of the impetigo treatment market.
5. Rise in Hospital-Acquired Infections: Hospital-acquired infections are contributing to the market's growth. Impetigo can be acquired in healthcare settings, making its treatment and prevention a priority.
6. Unhygienic Lifestyle Adoption in Developing Nations: The adoption of unhygienic lifestyles in developing nations is another factor driving market growth. Poor hygiene practices can lead to the spread of impetigo, necessitating treatment.
7. Demand for Broad Spectrum Antibiotics: The increasing demand for broad-spectrum antibiotics, which are effective against a wide range of bacteria, is fostering market expansion.
8. Research and Development Efforts: Ongoing research and development efforts aimed at improving the quality of impetigo treatment drugs are supporting market growth. Innovations in treatment options are enhancing the market's attractiveness.
9. Healthcare Spending: The increase in healthcare spending by individuals, healthcare providers, and governments is contributing to the impetigo market's growth by facilitating access to treatment.
10. Global Antibiotic Consumption: The global rise in antibiotic consumption, which increased by 65% between 2000 and 2015, is directly connected to the demand for antibiotics to treat impetigo.
These driving factors collectively contribute to the growth and expansion of the impetigo treatment market.
What Our Report Provides and Why Our Offering Is Superior This report offers historical data points, forecasts, and revenue growth at global, regional, and country levels. It provides analysis of industry trends and consumption patterns for each region, major country, and segment from 2019 to 2030. The global market report includes insights into industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and revenue share contributions for each regional and country market. Additionally, the report offers industry analysis and a competitive landscape, including company financials and impact analysis.
Key Market Trends and Innovation: The impetigo market is witnessing a trend toward new treatment options and combination drugs.
Clinical trials have been conducted to evaluate the safety and efficacy of topical application of mupirocin on children with impetigo in various locations.
Organic and Inorganic Strategies Adopted: In June 2019, Almirall collaborated with the American Acne and Rosacea Society (AARS) to raise awareness of the prevalence and effects of impetigo in the U.S. This collaboration is expected to enhance knowledge of skin disease treatments and their effectiveness.
Explore Trending Reports:
Temperature Controlled Packaging Solutions Market-https://www.globenewswire.com/news-release/2019/05/07/1818660/0/en/Global-Temperature-Controlled-Packaging-Solutions-Market-To-Reach-USD-18-01-Billion-By-2026-Reports-And-Data.html
Anti-Counterfeit Packaging Market-https://www.globenewswire.com/news-release/2019/09/05/1911804/0/en/Anti-Counterfeit-Packaging-Market-To-Reach-USD-248-90-Billion-By-2026-Reports-And-Data.html
Blow-Fill-Seal Technology Market-https://www.globenewswire.com/news-release/2019/10/01/1923555/0/en/Blow-Fill-Seal-Technology-Market-To-Reach-USD-452-6-Million-By-2026-Reports-And-Data.html
Oxygen Scavengers Market-https://www.globenewswire.com/news-release/2020/09/15/2094192/0/en/Oxygen-Scavengers-Market-To-Reach-USD-2-78-Billion-By-2027-Reports-and-Data.html
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/5355
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
